Best Urologists for Benign Prostatic Hyperplasia in India

Benign prostatic hyperplasia is a non-malignant enlargement of the prostate gland caused by an overgrowth of prostate tissue, which can partially or fully obstruct the flow of urine from the bladder through the urethra. It is not cancer and does not increase the risk of prostate cancer, but it does require evaluation and often management to prevent complications.

Common symptoms include a weak or intermittent urine stream, a frequent or urgent need to urinate (particularly at night, known as nocturia), difficulty starting urination, a feeling of incomplete bladder emptying, and, in more advanced cases, complete inability to urinate (acute urinary retention). Over time, untreated obstruction can contribute to bladder muscle changes, recurrent infections, or, less commonly, kidney impairment. It is important to note that the presence or severity of these symptoms alone is not sufficient to establish a diagnosis, as similar symptoms can arise from other urological or medical conditions.

Assessment typically begins with a structured symptom questionnaire — most commonly the International Prostate Symptom Score (IPSS) — alongside a digital rectal examination to estimate prostate size and texture. Investigations usually include a urinalysis to exclude infection or blood in the urine, a prostate-specific antigen (PSA) blood test to help differentiate BPH from other prostate conditions, and a urine flow rate study (uroflowmetry) combined with a post-void residual urine measurement to quantify how well the bladder is emptying. In selected cases, a urologist may recommend transrectal ultrasound for a more precise prostate volume measurement, or cystoscopy if the anatomy needs to be directly assessed.

The appropriate treatment for BPH depends on the severity of symptoms, the degree of urinary obstruction, prostate size, patient preference, and the presence of any complications — all of which must be evaluated on an individual basis by a qualified clinician. Mild-to-moderate symptoms without complications are often managed conservatively with lifestyle changes and, where appropriate, medication, while more significant obstruction or failed medical therapy typically warrants a procedural or surgical approach. Procedures available in specialist urology centres include transurethral resection of the prostate (TURP), Holmium laser enucleation of the prostate (HoLEP), and other laser-based prostate surgeries, each with different profiles of efficacy, recovery time, and suitability depending on prostate anatomy and overall health.

Meaningful non-surgical options exist for many men with BPH, particularly those with mild to moderate symptoms. Lifestyle modifications — such as reducing fluid intake in the evening, limiting caffeine and alcohol, and practising bladder training techniques — can reduce symptom burden. Medications including alpha-blockers (which relax the smooth muscle of the prostate and bladder neck) and 5-alpha reductase inhibitors (which gradually reduce prostate volume over months) are well-established first-line medical therapies, and a combination of both is sometimes used for moderate-to-severe cases. Active surveillance with periodic reassessment is also appropriate for men with mild, stable symptoms who prefer to defer treatment.

Transurethral resection of prostate (TURP) may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.

BPH is primarily evaluated and managed by a urologist — a specialist in diseases of the urinary tract and male reproductive system. In cases where medical treatment is being optimised before a referral for surgery, or where complicating conditions such as diabetes or cardiovascular disease are relevant, a primary care physician or internist may be involved in coordinating care alongside the urologist.

When choosing a urologist or urology centre for BPH, it is worth comparing the surgeon's specific experience with minimally invasive prostate procedures such as HoLEP and laser surgery, the volume of BPH procedures performed at the facility, access to urodynamic testing for thorough pre-operative assessment, and the quality of structured follow-up to monitor urinary function after treatment.

Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.

Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.